Esperion Therapeutics, Inc.
ESPRDelisted Jul 13, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434868
Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 191 institutions reported holding it in 13F filings for Q2 2026, worth $646.8M in total; Soros Fund Management was the only superinvestor holding it.
Q1 2024 vs. Q4 2023
How the institutions holding Esperion Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 132 | 1 | 152 | +21 |
| Shares | 71.9M | 24.4K | 125.5M | +53.5M (+74.5%) |
| Value | $215.3M | $73.0K | $336.2M | +$120.9M (+56.2%) |
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (43)
Institutions that held Esperion Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (22)
Institutions that held Esperion Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Armistice Capital, LLC | 3,200,000 | $9.57M |
| Tang Capital Management LLC | 1,850,000 | $5.53M |
| Whitefort Capital Management, LP | 885,522 | $2.65M |
| Connor, Clark & Lunn Investment Management Ltd. | 352,054 | $1.05M |
| Ikarian Capital, LLC | 337,636 | $1.01M |
| Monaco Asset Management SAM | 243,642 | $728.5K |
| Highbridge Capital Management LLC | 221,722 | $662.9K |
| Silverback Asset Management LLC | 100,000 | $603.1K |
| 683 Capital Management, LLC | 134,689 | $402.7K |
| Boston Private Wealth LLC | 60,554 | $181.1K |
| Engineers Gate Manager LP | 52,932 | $158.3K |
| Mirabella Financial Services LLP | 42,200 | $126.2K |
| Graham Capital Management, L.P. | 41,733 | $124.8K |
| Caption Management, LLC | 31,600 | $94.5K |
| Cetera Advisor Networks LLC | 12,500 | $37.4K |
| Chicago Partners Investment Group LLC | 15,066 | $30.6K |
| Captrust Financial Advisors | 10,050 | $30.1K |
| Private Portfolio Partners LLC | 10,000 | $29.9K |
| O'Dell Group, LLC | 4,500 | $13.5K |
| Headlands Technologies LLC | 3,208 | $9.59K |
| Advisory Services Network, LLC | 62 | $185 |
| TD Waterhouse Canada Inc. | 60 | $185 |
Not filed for Q1 2024 yet (1)
Institutions that held Esperion Therapeutics, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Sawtooth Solutions, LLC | 24,398 | $73.0K |